/R E P E A T -- Merck to announce multi-million dollar investment towards Montréal's life sciences research sector/

/R E P E A T -- Merck to announce multi-million dollar investment towards 
Montréal's life sciences research sector/ 
Join one of Canada's top R&D investors on Monday, November 26, at the Centre 
Sheraton Montréal 
KIRKLAND, QC, Nov. 22, 2012 /CNW Telbec/ -Members of the media are invited 
to attend a press conference during which a multi-million dollar investment 
towards the growth of the life sciences research sector in Montréal will be 
announced in the company of: CyrilSchiever, President and Managing Director, 
Merck Canada Inc.; Martin Leblanc, Vice-Chairman of the Board, Montréal 
InVivo; Dr.Vassilios Papadopoulos, Executive Director and Chief Scientific 
Officer, Research Institute of the McGill University Health Centre (RI-MUHC); 
Dr.JacquesTurgeon, Director, CRCHUM and Dr.Jean-Claude Tardif, Director, 
Montréal Heart Institute Research Centre. The press conference will be 
followed by a round table featuring Montréal's next generation of researchers. 
WHEN:    Monday, November 26(th), 2012 at 10:00 a.m. 


         10:00 a.m.    Press conference begins
         10:30 a.m.    Q&A
         10:40 a.m.    One-on-one interviews and photo opportunity
         11:15 a.m.    Round table discussion with Montréal's next
                       generation of researchers
         12:30 p.m.    Lunch
    WHERE:   Centre Sheraton Montréal
         1201 Rene-Levesque West Blvd., Montréal, H3B 2L7
         Drummond Room





Stephanie Lyttle 514-843-2365 514-501-8685 (cell) slyttle@national.ca

SOURCE: MERCK

To view this news release in HTML formatting, please use the following URL: 
http://www.newswire.ca/en/releases/archive/November2012/26/c3102.html

CO: MERCK
ST: Quebec
NI: MTC MED HEA 

-0- Nov/26/2012 10:59 GMT